| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $652.5M | +19.2% |
| Cost of Revenue | $64.5M | +14.1% |
| Gross Profit | $588.0M | +19.8% |
| R&D Expense | $324.7M | +9.2% |
| SG&A Expense | $141.3M | -15.0% |
| Operating Income | -$270.0M | +33.8% |
| Interest Expense | $4.0M | +97.6% |
| Pre-tax Income | -$253.3M | +37.1% |
| Income Tax | $3.7M |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $236.7M | -55.1% |
| Accounts Receivable | $88.3M | +7.2% |
| Current Assets | $659.7M | -0.1% |
| Total Assets | $962.0M | +0.7% |
| Current Liabilities | $367.2M | +10.5% |
| Total Liabilities | $635.6M | +6.2% |
| Stockholders' Equity | $326.4M | -8.5% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.9M | +88.8% |
| Capital Expenditures | $7.7M | +44.3% |
| Investing Cash Flow | -$289.1M | -548.3% |
| Financing Cash Flow | $16.8M | -95.6% |
| Free Cash Flow | -$25.7M | +84.5% |
| -24.0% |
| Net Income | -$257.0M | +37.0% |
| EPS (Basic) | -$1.17 | +42.6% |
| EPS (Diluted) | -$1.17 | +42.6% |